Doctors who perform in vitro fertilization typically rely on a visual assessment of the embryos when deciding which ones to transfer into the uterus, but two-thirds of such embryos fail to implant. A new test analyzes the proteins and small-molecule metabolites in the fluid surrounding each embryo and compares the resulting metabolic profile with that of a healthy embryo. The test improves implantation rates up to 30 percent. That means doctors can transfer fewer embryos, reducing the chances of an undesired multiple pregnancy.
Courtesy of Molecular Biometrics
Cost: $30,000 to $50,000 for the testing system in the U.S. market. (Tests will not add appreciably to the typical cost of $12,000 to $15,000 for an IVF treatment.)
Availability: Now in the U.K., Australia, Japan, Ireland, and Greece; seeking FDA approval in the U.S.
Company: Molecular Biometrics
Other products in this section:
How AI is reinventing what computers are
Three key ways artificial intelligence is changing what it means to compute.
These weird virtual creatures evolve their bodies to solve problems
They show how intelligence and body plans are closely linked—and could unlock AI for robots.
We reviewed three at-home covid tests. The results were mixed.
Over-the-counter coronavirus tests are finally available in the US. Some are more accurate and easier to use than others.
A horrifying new AI app swaps women into porn videos with a click
Deepfake researchers have long feared the day this would arrive.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.